Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats

Keyphrases

• Abdominal 12%
• AM630 25%
• Angiogenesis 100%
• Bile Duct Ligation 75%
• Cannabinoid Receptor 1 (CB1R) 25%
• Cannabinoid Receptor 2 100%
• Cannabinoids 37%
• Cirrhosis 25%
• Collateral Growth 12%
• Common Bile Duct Ligation 12%
• Concomitant Use 12%
• Cyclooxygenase-1 (COX-1) 50%
• Cyclooxygenase-2 37%
• Endothelial Nitric Oxide Synthase (eNOS) 25%
• Factor Level 12%
• Fibrosis 25%
• Hepatic Encephalopathy 12%
• Hyperemia 12%
• Intrahepatic Angiogenesis 25%
• JWH133 12%
• Left Adrenal Vein 12%
• Lethal Complication 12%
• Liver Cirrhosis 12%
• Mesenteric Arterial Blood Flow 12%
• Mesentery 12%
• Messenger RNA Expression 12%
• Plasma Vascular Endothelial Growth Factor 12%
• Portal Hypertension 25%
• Portal Pressure 12%
• Portosystemic Collaterals 100%
• Portosystemic Shunting 25%
• Protein Expression 12%
• Sham 37%
• Shunt 12%
• Splenorenal Shunt 25%
• Superior Mesenteric 12%
• Variceal Hemorrhage 12%
• Vascular Density 25%
• Vascular Endothelial Growth Factor 12%
• Vascular Endothelial Growth Factor Receptor (VEGFR) 12%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 25%

Medicine and Dentistry

• 6 Iodo 3 (4 Methoxybenzoyl) 2 Methyl 1 (2 Morpholinoethyl)indole 28%
• Angiogenesis 100%
• Artery Blood Flow 14%
• Bile Duct Ligation 100%
• Bleeding 14%
• Cannabinoid 85%
• Cannabinoid 2 Receptor 28%
• Cannabinoid 2 Receptor Agonist 100%
• Cannabinoid Receptor 42%
• Common Bile Duct 14%
• Cyclooxygenase 1 42%
• Cyclooxygenase 2 42%
• Downregulation 14%
• Endothelial Nitric Oxide Synthase 28%
• Fibrosis 28%
• Hemodynamic 14%
• Hepatic Encephalopathy 14%
• Hyperaemia 14%
• Liver Cirrhosis 42%
• Mesentery 14%
• Portal Hypertension 28%
• Portal Venous Pressure 14%
• Portosystemic Anastomosis 28%
• Prostaglandin Synthase 14%
• Protein Expression 14%
• Splenorenal Shunt 28%
• Vasculotropin 28%
• Vasculotropin Receptor 1 14%
• Vasculotropin Receptor 2 28%

Biochemistry, Genetics and Molecular Biology

• Agonist 100%
• Angiogenesis 100%
• Artery Blood Flow 12%
• Cannabinoid 100%
• Cannabinoid Receptor 100%
• Cannabinoid Receptor Type 1 12%
• Cannabinoid Receptor Type 2 12%
• Cyclooxygenase 87%
• Downregulation 12%
• Eicosanoid Receptor 12%
• Hemodynamic 12%
• Kinase Insert Domain Receptor 25%
• Messenger RNA 12%
• Nitric Oxide Synthase 25%
• Portal Vein Blood Pressure 12%
• Protein Expression 12%
• Vascular Endothelial Growth Factor 25%